Baker Brothers latest buys and sells
16 additions in Baker Brothers's latest 13F filing, largest first. The largest is the addition to RVMD, $353.6M or 1.8% of the reported portfolio.
Key facts
- Additions
- 16
- Largest move
- RVMD, $353.6M
- Latest filing
- Aug 14, 2026
From Baker Bros. Advisors's filing for (Q2 2026), filed , against the filing for Mar 31, 2026.
| # | Stock | Move | Shares | Size | Of portfolio |
|---|---|---|---|---|---|
| 1 | Revolution Medicines IncRVMD | ▲ Added 20% | +1.89M | $353.6M | 1.77% |
| 2 | Insmed IncINSM | ▲ Added 19% | +1.38M | $146.6M | 0.73% |
| 3 | IDEAYA Biosciences IncIDYA | ▲ Added 27% | +1.06M | $39.6M | 0.20% |
| 4 | Relay Therapeutics IncRLAY | ▲ Added 144% | +1.67M | $31.2M | 0.16% |
| 5 | Abcellera Biologics IncABCL | ▲ Added 9.0% | +2.74M | $21.5M | 0.11% |
| 6 | Celldex Therapeutics IncCLDX | ▲ Added 78% | +517.25K | $19.2M | 0.10% |
| 7 | Arcus Biosciences IncRCUS | ▲ Added 103% | +429.2K | $13.2M | 0.07% |
| 8 | Viridian Therapeutics IncVRDN | ▲ Added 21% | +411.3K | $7.6M | 0.04% |
| 9 | Verastem IncVSTM | ▲ Added 327% | +1.91M | $7.3M | 0.04% |
| 10 | Incyte CorpINCY | ▲ Added 0.06% | +18.45K | $2.1M | 0.01% |
| 11 | Design Therapeutics IncDSGN | ▲ Added 3.6% | +92.57K | $1.3M | 0.01% |
| 12 | Madrigal Pharmaceuticals IncMDGL | ▲ Added 0.07% | +1.5K | $805K | 0.00% |
| 13 | Beone Medicines LtdONC | ▲ Added 0.03% | +2.64K | $752.2K | 0.00% |
| 14 | Kiniksa Pharmaceuticals InternationalKNSA | ▲ Added 0.3% | +8.48K | $542.2K | 0.00% |
| 15 | Acadia Pharmaceuticals IncACAD | ▲ Added 0.04% | +17.16K | $434.1K | 0.00% |
| 16 | Denali Therapeutics IncDNLI | ▲ Added 0.07% | +2.61K | $67.2K | 0.00% |
Questions and answers
What did Baker Brothers buy last quarter?
The largest purchases in the latest 13F filing: RVMD, $353.6M; INSM, $146.6M; IDYA, $39.6M; RLAY, $31.2M; ABCL, $21.5M; CLDX, $19.2M.
How is the size of a buy or sell worked out?
As the change in shares at the price the filing implies for the quarter's end (reported value divided by shares) — an estimate of the trade, not what was paid. A position sold out is sized at its value in the previous filing.
Learn
Cite this page
Funkfolio, “Baker Brothers: buys and sells, Q2 2026 13F”, data as of 14 August 2026. https://funkfolio.com/gurus/activity?type=added&investor=baker-brothers
Underlying data: SEC EDGAR, Form 13F-HR.
Source: SEC EDGAR, Form 13F-HR. A move is a change in share count between an investor's latest filing and the one before; a share split in between is allowed for where one is on record. Size is the shares bought or sold at the price the filing implies for the period end (reported value ÷ shares) — an estimate of the trade, not what was paid — and a position sold out is sized at its value in the previous filing. “Of portfolio” sets that size against the portfolio reported for the period. Only each investor's 150 largest positions and 50 largest exits are read. Filings appear up to 45 days after the quarter ends; none of this is advice.